| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |